What is the price target for CSBR stock?
7 analysts have analysed CSBR and the average price target is 12.24 USD. This implies a price increase of 113.24% is expected in the next year compared to the current price of 5.74.
CHAMPIONS ONCOLOGY INC (CSBR) Forecast, Price Target & Analyst Ratings
NASDAQ:CSBR • US15870P3073
Current stock price
5.74 USD
-0.01 (-0.17%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHAMPIONS ONCOLOGY INC (CSBR).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Jul 21, 2026
- Period
- Q4 / 2026
- EPS Estimate
- -$0.05
- Revenue Estimate
- 13.144M
Price Target Details & History
Consensus Price Target and Range
Mean target
$12.24
Upside
+ 113.24%
From current price of $5.74 to mean target of $12.24, Based on 7 analyst forecasts
Low
$12.12
Median
$12.24
High
$12.60
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for CSBR. The average price target is 12.24 USD. This implies a price increase of 113.24% is expected in the next year compared to the current price of 5.74.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
CSBR was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CSBR.
In the previous month the buy percentage consensus was at a similar level.
CSBR was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-03-12 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-12-12 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-12 | Craig-Hallum | Upgrade | Hold -> Buy |
| 2024-03-13 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2023-09-22 | Roth MKM | Maintains | Buy -> Buy |
| 2021-03-15 | Roth Capital | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Jul 21, 2026
- Period
- Q4 / 2026
- EPS Estimate
- -$0.05
- Revenue Estimate
- 13.144M
- Revenue Q2Q
- 6.39%
- EPS Q2Q
- 27.14%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
-200.00%
Next Earnings Summary
CSBR is expected to report earnings on 7/21/2026. The consensus EPS estimate for the next earnings is -0.05 USD and the consensus revenue estimate is 13.14M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 53.87M 9.69% | 50.155M -6.90% | 56.944M 13.54% | 59.7M 4.84% | 66.569M 11.51% | 95.925M 44.10% | 113.19M 18.00% | 133.57M 18.01% | 97.007M -27.37% | 106.71M 10.00% | 116.84M 9.49% | |
| EBITDA YoY % growth | -2.2M -198.21% | -5.054M -129.73% | 6.486M 228.33% | 1.686M -74.01% | 1.454M -13.76% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.45M -829.51% | -6.921M -55.53% | 4.846M 170.02% | -1.385M -128.58% | -2.152M -55.38% | 9.592M 545.68% | 14.148M 47.50% | 18.032M 27.45% | 9.7M -46.21% | 13.339M 37.52% | 14.605M 9.49% | |
| Operating Margin | -8.26% | -13.80% | 8.51% | -2.32% | -3.23% | 10.00% | 12.50% | 13.50% | 10.00% | 12.50% | 12.50% | |
| EPS YoY % growth | -0.39 -1,400.00% | -0.49 -25.64% | 0.45 191.84% | 0.12 -72.80% | 0.10 -16.67% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 26 | Q1 / 27 | Q2 / 27 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.05 27.14% | -0.01 -151.00% | 0.02 2.00% |
| Revenue Q2Q % growth | 13.144M 6.39% | 15.346M 9.65% | 16.7M 11.04% |
| EBITDA Q2Q % growth | -808.86K -993.05% | -180.54K -21.17% | 372.3K -58.63% |
| EBIT Q2Q % growth | -1.545M 9.84% | -1.048M -106.62% | -510K -375.68% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
18.44%
Revenue Next 5 Year
18.26%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
CHAMPIONS ONCOLOGY INC / CSBR Forecast FAQ
When does CHAMPIONS ONCOLOGY INC (CSBR) report earnings?
CHAMPIONS ONCOLOGY INC (CSBR) will report earnings on 2026-07-21, after the market close.
What are the consensus estimates for CHAMPIONS ONCOLOGY INC (CSBR) next earnings?
The consensus EPS estimate for the next earnings of CHAMPIONS ONCOLOGY INC (CSBR) is -0.05 USD and the consensus revenue estimate is 13.14M USD.
What is the consensus rating for CHAMPIONS ONCOLOGY INC (CSBR) stock?
The consensus rating for CHAMPIONS ONCOLOGY INC (CSBR) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.